1. Home
  2. BIO vs HQY Comparison

BIO vs HQY Comparison

Compare BIO & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • HQY
  • Stock Information
  • Founded
  • BIO 1952
  • HQY 2002
  • Country
  • BIO United States
  • HQY United States
  • Employees
  • BIO N/A
  • HQY N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • HQY Business Services
  • Sector
  • BIO Industrials
  • HQY Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • HQY Nasdaq
  • Market Cap
  • BIO 9.2B
  • HQY 8.4B
  • IPO Year
  • BIO N/A
  • HQY 2014
  • Fundamental
  • Price
  • BIO $279.94
  • HQY $108.60
  • Analyst Decision
  • BIO Strong Buy
  • HQY Buy
  • Analyst Count
  • BIO 4
  • HQY 13
  • Target Price
  • BIO $414.00
  • HQY $111.23
  • AVG Volume (30 Days)
  • BIO 273.5K
  • HQY 703.3K
  • Earning Date
  • BIO 02-13-2025
  • HQY 03-18-2025
  • Dividend Yield
  • BIO N/A
  • HQY N/A
  • EPS Growth
  • BIO N/A
  • HQY 218.51
  • EPS
  • BIO N/A
  • HQY 1.09
  • Revenue
  • BIO $2,566,500,000.00
  • HQY $1,150,344,000.00
  • Revenue This Year
  • BIO $4.19
  • HQY $20.65
  • Revenue Next Year
  • BIO $4.75
  • HQY $9.04
  • P/E Ratio
  • BIO N/A
  • HQY $99.81
  • Revenue Growth
  • BIO N/A
  • HQY 18.47
  • 52 Week Low
  • BIO $262.12
  • HQY $65.01
  • 52 Week High
  • BIO $387.99
  • HQY $115.59
  • Technical
  • Relative Strength Index (RSI)
  • BIO 26.04
  • HQY 49.08
  • Support Level
  • BIO $273.67
  • HQY $110.50
  • Resistance Level
  • BIO $289.96
  • HQY $115.22
  • Average True Range (ATR)
  • BIO 11.05
  • HQY 2.90
  • MACD
  • BIO -6.71
  • HQY -0.64
  • Stochastic Oscillator
  • BIO 7.40
  • HQY 7.97

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Share on Social Networks: